HORMONE REPLACEMENT IN CASE OF OSTEOPOROSIS: WHAT ARE THE RISKS ASSOCIATED WITH HORMONE THERAPY?
While there seems to be little doubt that hormone therapy can be beneficial in the treatment of osteoporosis in postmenopausal women, there are significant hazards that have to be considered. Oestrogen is a powerful chemical which has an impact on many systems in the body.
If you have had serious problems in the past with oral contraceptives, then oestrogen or hormone therapy should perhaps not be undertaken. Hormone therapy probably would not be prescribed if you are overweight, have high blood pressure, varicose veins, seizure disorders, diabetes, liver or gallbladder disease, undiagnosed vaginal bleeding, migraine headaches, or smoke heavily..
There is an increased risk of blood clotting. Since oestrogens are usually taken orally, they go immediately to the liver in a relatively high concentration, overstimulating this organ.
Oestrogens used in menopausal therapy and high-oestrogen birth-control Pills have both been linked to cancer of the endometrium. During the years you arc menstruating, one of the normal effects of natural oestrogen is stimulation of the lining of the uterus (endometrium), and in the menstrual cycle progesterone is produced as a counterbalance, triggering the shedding of the uterus lining. When the stimulation caused by oestrogen supplements is ‘unopposed’ by progestin, it can produce an overgrowth or thickening of the endometrium which can precede endometrial cancer, especially if you have never borne a child. This risk can be diminished, however, if oestrogen therapy is supplemented with progestin. If you have a family history of endometrial cancer, or if you are overweight (and producing oestrogens derived from your androgen hormones), or if you have a menstrual cycle that does not naturally produce progesterone, you would be at high risk when taking unopposed oestrogens.
If, on the other hand, your family has a medical history of heart disease, women’s natural hormones apparently give protection before menopause; but when hormone production stops, the rate of women’s heart disease quickly rises to equal that of men. And while oestrogen supplements appear to reduce heart disease risks, combined oestrogen/progestin therapy can erase the cardiovascular protection of oestrogen.
Another side effect may be tender swollen breasts and the possibility of breast cancer after long-term therapy (although this is controversial among medical researchers). If other female members of your family have had breast cancer, or if you have a tendency to have cystic breasts, you may have an increased danger of developing cancer of the breast if prescribed oestrogens. A Swedish study reported in 1989 showed that women taking a combination of oestrogen/progestin for more than six years were more than four times as likely as other women to develop breast cancer.
If you take hormones for more than a year, you may have a deficiency of vitamin B, which can give you a feeling of depression. This deficiency can be offset by eating organ meats, wholegrain breads and dark leafy vegetables, or taking a folate supplement.
Other drawbacks to hormone therapy can be weight increase, fluid retention and headaches, but a low-sodium diet can help in many cases. Your doctor may also mention other side effects of nausea, vomiting, abdominal cramps and dizziness.
Before starting hormone therapy, your physician will give you a thorough examination including tests for liver disease, hypertension or heart disease, existing breast or endometrial cancer that would rule out the taking of oestrogen supplements. There should be a Pap test of your cervix and a suction curettage of your uterus, with a biopsy to ensure there are no cancerous or precancerous cell tissues or pre-existing fibroids.
During therapy you will need to be under close surveillance by your physician, with examinations every six months. Mammography, Gravely jet-washing of the uterus or further biopsies may be necessary to ensure there is no development of cancer and for tests to evaluate your rate of bone loss. If undesirable thickening of the endometrium occurs, your doctor can reduce dosage or change the type of hormone. Any unusual blood spotting should immediately be reported to your physician. If therapy is begun while you are still menstruating, your usual bleeding pattern should continue, and may extend into your sixties.
Summary
If you decide on hormone replacement therapy, try to have the smallest possible dosage for the shortest possible time to avoid the possibility of cancer – but sufficient to maintain bone mass. The preferred method to minimize risks is to have natural oestrogens in conjunction with progestin on a monthly cycle, but there is as yet little information about the safety of long-term treatment.
With hormone treatment containing risks, it should not be considered routine for all women, but if you are at high risk of developing brittle bones, there is no doubt that it can be extremely valuable.
In April 1984, a US Government-sponsored Conference on Osteoporosis attended by eminent research specialists and physicians, issued a consensus statement: ‘Until more data on risks and benefits are available, physicians and patients may prefer to reserve oestrogen (with or without progestogen) therapy for conditions that confer a high risk of osteoporosis, such as the occurrence of premature menopause.’
If you decide not to have HRT, make sure you have dietary calcium up to 1500mg daily, with adequate vitamins D and C, and plenty of exercise to keep bones strong. If you are prescribed HRT, your doctor may consider that 1000mg of calcium, plus vitamins and exercise, is sufficient.
*55\114\2*